ImmuneFDA Approved
Enfuvirtide
Fuzeon
A 36-amino acid peptide functioning as an HIV fusion inhibitor that prevents viral entry into cells. The first approved drug in its class.
FDA Approved90 mg subcutaneous twice daily
Peptide Database
Browse Research Peptides
Comprehensive profiles for 105+ peptides — dosing protocols, mechanisms of action, clinical research, and safety data.
105
Peptides
9
Categories
7 peptides match your filters
ImmunePreclinical
KPV
Lys-Pro-Val
A tripeptide derived from alpha-melanocyte stimulating hormone (α-MSH). Known for potent anti-inflammatory effects, particularly in the gut.
Animal Studies200-500 mcg daily
ImmuneIn Clinical Trials
LL-37
Cathelicidin
A naturally occurring antimicrobial peptide and the only human cathelicidin. Part of the innate immune system with broad-spectrum antimicrobial activity.
Clinical Trials100-200 mcg daily
ImmunePreclinical
PNC27
PNC-27
A peptide containing p53 binding domain (residues 12-26) fused to membrane-penetrating peptide. Selectively targets cancer cells expressing HDM-2 on plasma membranes.
Animal StudiesNo human dose established - research compound only
ImmuneNot FDA Approved
Thymogen
EW Dipeptide
A synthetic dipeptide (Glu-Trp) bioregulator derived from Thymalin, representing one of Professor Khavinson's key immunomodulatory compounds.
Clinical Trials1-2 capsules (10-20 mg) daily
ImmuneNot FDA Approved
Thymosin Alpha-1
Ta1
A naturally occurring thymic peptide that enhances immune function.
Clinical Trials1.6 mg twice weekly
ImmuneIn Clinical Trials
VIP
Vasoactive Intestinal Peptide
A naturally occurring peptide exhibiting immunomodulatory and anti-inflammatory properties being investigated for ARDS, pulmonary hypertension, and autoimmune disorders.
Clinical Trials50-100 mcg intranasal daily